Clinical trial
Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma…
NCT00462488 · Sesen Bio, Inc., Industry · Completed
Key facts
| NCT number | NCT00462488 |
|---|---|
| Title | Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ |
| Official title | Phase II Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Patients With Non-Invasive Urothelial Carcinoma in Situ (CIS) Previously Treated With Bacille Calmette-Guérin (BCG) |
| Lead sponsor | Sesen Bio, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urinary Bladder Cancer, Bladder Cancer, Bladder Neoplasms, Bladder Tumors |
| Intervention type | Drug |
| Interventions | Vicinium |
| Enrollment | 46 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Apr 19, 2007 |
| Last update posted | May 12, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: